LBA
REPL icon

Letko, Brosseau & Associates’s Replimune Group REPL Stock Holding History

Letko, Brosseau & Associates’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.6K Hold
10,800
– – ﹤0.01% 97
2025
Q4 		$105K Hold
10,800
– – ﹤0.01% 96
2025
Q3 		$45.3K Hold
10,800
– – ﹤0.01% 97
2025
Q2 		$100K Buy
+10,800
New +$94.2K ﹤0.01% 91
2023
Q1 		– Sell
-7,525
Closed -$205K – 95
2022
Q4 		$205K Sell
7,525
-15,275
-67% -$317K ﹤0.01% 93
2022
Q3 		$394K Hold
22,800
– – 0.01% 87
2022
Q2 		$399K Hold
22,800
– – 0.01% 87
2022
Q1 		$387K Hold
22,800
– – 0.01% 91
2021
Q4 		$618K Hold
22,800
– – 0.01% 92
2021
Q3 		$676K Hold
22,800
– – 0.01% 91
2021
Q2 		$876K Hold
22,800
– – 0.01% 92
2021
Q1 		$696K Hold
22,800
– – 0.01% 90
2020
Q4 		$870K Sell
22,800
-19,600
-46% -$817K 0.01% 94
2020
Q3 		$976K Buy
+42,400
New +$966K 0.02% 83

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Letko, Brosseau & Associates's REPL Position: Q1 2026 in Review

Letko, Brosseau & Associates held its Replimune Group (REPL) position steady in Q1 2026 at 10,800 shares worth $82.6K. The position accounts for ﹤0.01% of the portfolio, ranked #97.

Letko, Brosseau & Associates first reported a position in REPL in Q3 2020 and has held it in 14 quarters since. The position peaked at $976K in Q3 2020. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Letko, Brosseau & Associates held 10,800 shares of Replimune Group worth $82.6K as of Q1 2026.
  • Letko, Brosseau & Associates left its Replimune Group share count unchanged in Q1 2026.
  • Replimune Group made up ﹤0.01% of Letko, Brosseau & Associates's portfolio in Q1 2026, its #97 holding.
  • Letko, Brosseau & Associates first reported a position in Replimune Group in Q3 2020 and has held it in 14 quarters since.
  • Letko, Brosseau & Associates's Replimune Group position peaked at $976K in Q3 2020.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Letko, Brosseau & Associates's 13F filing for Q1 2026, filed 12 May 2026.